Company
Company

Relevant Interviews, Webinar and Trial Updates posted by CRISPR Medicine News.

Always stay updated with the free CMN Newsletter.

SNIPR Biome

Main focus: Treatment of bacterial infections

Company stage: Pre-clinical

Diseases: Bloodstream infections caused by E. coli, other infections

Genome editing tool: CRISPR-Cas

Funding stage: Private

Location: Copenhagen, Denmark

Website: https://www.sniprbiome.com/

Partners: Novo Nordisk

SNIPR Biome is a Danish, pre-clinical stage company. The company is focused on novel CRISPR-based antibacterial therapies. The company has patents on several CRISPR-Cas technologies including the Cas9, Cas3 and Cas12a enzymes. While SNIPR Biome has not revealed an official pipeline, it has disclosed the use of its DNA-based CRISPR-guided vector platform to generate next-generation antibiotic therapies.

Tags

HashtagSNIPR Biome

close
Search CRISPR Medicine